Vendor, Torrance, CA
Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
UEI LTJVF4QSFCP9, CAGE 1J6D9
2 awards and $260,328 obligated between August 6, 2026 and August 10, 2026, 100% under full and open competition, against 3.5 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Professional, Scientific, and Technical ServicesNAICS 541711 | $224,332 |
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $35,996 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 2 |
| Delivery Order | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| HHSN27500007Delivery Order, August 6, 2026, Full and Open Competition, 2 offers | National Institutes of Health NichdNational Institutes of Health | Nichd: R&d: Clinical Treatment of Nestorone Gel and Testosterone Gel for Male Contraception: Non-SeverableNAICS 541711, PSC AN12 | $224,332 |
| 75N94020F00001Delivery Order, August 10, 2026, Full and Open Competition, 5 offers | National Institutes of Health NichdNational Institutes of Health | Nichd: R&d: Core Function Activities: SeverableNAICS 541714, PSC AN12 | $35,996 |
- Places of performance
- California
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 2 across 2 awards